Sep 21, 2017 - Book partial profits on STMicroelectronics.Intercept Pharmaceuticals is a speculative biotech with positive news.Array BioPharma has the money to expand its portfolio.
Sep 18, 2017 - The Weekly Pharma Scoop has become daily as of today.ACADIA's growth potential in PDP and also in ADP is discussed.Lexicon's slump following positive data and its interpretation by a Seeking Alpha con
Sep 15, 2017 - Altice (OTCPK:ATCEY) is expanding its deal with Arris (ARRS +0.6%) to enable a multinational deployment of new 4K HDR set-top boxes starting in 2018. Altice-owned Portugal Telecom had selected Arris
Sep 14, 2017 - A Boulder biotech said it's commenced an underwritten public offering of about $200 million of its stock.
Array BioPharma Inc. said it's begun an offering of $175 million of shares of its common stock, and it's giving underwriters the option to buy up to an additional $26 million in shares.
"We intend to use the net proceeds from this offering to fund our research and development efforts, including clinical trials for our proprietary candidates, build and scale commercial capability, and for general…
Sep 13, 2017 - Steven Cohen Dives Into Array BioPharma, Stocks: ARRY,PCRX,AKAO,BIIB,JNJ, Steven Cohen, release date:Sep 13, 2017
Sep 11, 2017 - This is the once-weekly Pharma scoop published by the Total Pharma Tracker.In today's analysis, Valeant's CRL issue may be resolved soon.Array Biopharma showed positive results in phase 3 trials.
Sep 11, 2017 -
The 2017 ESMO Congress wraps up on Tuesday in Madrid, Spain. On Monday, Jefferies issued a handful of flash notes related to companies presenting at the conference.
Here’s a breakdown of the highlights.
Sep 11, 2017 - Stifel issues rating change for ARRY
Sep 08, 2017 - Nasdaq has suspended trading in Array BioPharma (ARRY +5.1%) pending the release of news.
Sep 06, 2017 - The company's lead candidates took another step forward last month.